GB1297261A - - Google Patents

Info

Publication number
GB1297261A
GB1297261A GB1297261DA GB1297261A GB 1297261 A GB1297261 A GB 1297261A GB 1297261D A GB1297261D A GB 1297261DA GB 1297261 A GB1297261 A GB 1297261A
Authority
GB
United Kingdom
Prior art keywords
jan
compositions
paracetamo
exicipients
hydroxyacetanilide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1297261A publication Critical patent/GB1297261A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1297261 Antipyretic &c compositions E R SQUIBB & SONS Inc 13 Jan 1970 [13 Jan 1969] 1935/69 Heading A5B [Also in Division C2] Pharmaceutical compositions, suitable for oral administration and having analgesic and anti pyretic activities, contain a anti pyrine (2,3 - dimethyl - 1 - phenyl - 3 - pyrazolin - 5 - one) - paracetamo (4' - hydroxyacetanilide) complex and conventional exicipients, binders, lubricants, and flavours.
GB1297261D 1969-01-13 1969-01-13 Expired GB1297261A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB193569 1969-01-13

Publications (1)

Publication Number Publication Date
GB1297261A true GB1297261A (en) 1972-11-22

Family

ID=9730621

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1297261D Expired GB1297261A (en) 1969-01-13 1969-01-13

Country Status (5)

Country Link
CA (1) CA948642A (en)
CH (1) CH507253A (en)
DE (1) DE2000210A1 (en)
FR (1) FR2034467B1 (en)
GB (1) GB1297261A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074474A2 (en) * 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US8362062B2 (en) 2002-02-15 2013-01-29 Mcneil-Ppc, Inc. Pharmaceutical compositions with improved dissolution

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10130504B4 (en) 2001-06-25 2005-02-03 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Xanthine and phenazone acesulfame H complexes with improved taste, process for their preparation and their use

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US8362062B2 (en) 2002-02-15 2013-01-29 Mcneil-Ppc, Inc. Pharmaceutical compositions with improved dissolution
WO2003074474A2 (en) * 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
WO2003074474A3 (en) * 2002-03-01 2003-12-18 Univ South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US10633344B2 (en) 2002-03-01 2020-04-28 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US8492423B2 (en) 2002-12-30 2013-07-23 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions

Also Published As

Publication number Publication date
FR2034467A1 (en) 1970-12-11
CA948642A (en) 1974-06-04
DE2000210A1 (en) 1970-07-23
CH507253A (en) 1971-05-15
FR2034467B1 (en) 1974-04-12

Similar Documents

Publication Publication Date Title
IE40025B1 (en) Hexahydro-dibenzo (b,d) pyran-9-ones as psychotropic or sedative drugs
GB1297261A (en)
GB1491503A (en) Method of preventing and treating thrombosis
GB1202148A (en) Pharmaceutical compositions
GB1216295A (en) New enzyme inhibitors and their preparation
IE33207L (en) Pharmaceutical compositions containing diazacarbazole
GB1270049A (en) New pharmaceutical product
GB1381649A (en) Medicine comprising lysine by-products
CA968273A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING M-TYROSINE AND .alpha.-HYDRAZINO-3,4-DIHYDROXYPHENYLPROPIONIC ACID
GB1242976A (en) A crystalline l-asparaginase preparation
CA985630A (en) Pharmaceutical composition having analgesic and antiphlogistic activities
AU3695971A (en) Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione
GB1351853A (en) Salicylate derivative
IE35711L (en) Pharmaceutical compositions
CA948109A (en) Pharmaceutical compositions containing 2-(t-butylamino)-1-((4-hydroxy-3-hydroxymethyl)phenyl)ethanol and a 6,8-dialkyl-s-triazolo(4,3-a)pyrazine
GB1233150A (en)
GB1446615A (en) Pharmaceutical compositions containing an anti-allergy drug
CA953217A (en) Pharmaceutical composition containing saccharides oligofructosans, polyfructosans and kestoses
GB1250279A (en)
GB1242742A (en) Drug for stimulating the central nervous system
GB1217138A (en) Pharmaceutical compositions based on derivatives of benzimidazole
CA974882A (en) ANALGESIC COMPOSITIONS CONTAINING .alpha.-D-PROPOXYPHENE AND CHLORDIAZEPOXIDE
GB1422046A (en) Pharmaceutical compositions
GB1329130A (en) Isoindolo 1,2-b benzothiazol-11 -4bh- one 5-oxides
IE36809L (en) Glucocorticoid-like water diuretic.

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees